Grant: Fellowship - Priority Announcement: Gastroenterology
University of Calgary
$30,740.00
Mitochondria, endoplasmic reticulum (ER stress) and autophagy regulate gut permeability
FY 2015-16
Summary
Canada has one of the highest global incidences and prevalence of inflammatory bowel diseases (IBD). The IBDs, Crohn's disease and ulcerative colitis, are chronic, painful and severely debilitating conditions characterized by relapsing bouts of disease with water/bloody diarrhea, which significantly reduce a patients' and their care-givers quality-of-life. IBD is idiopathic and cures await discovery. Current therapies, such as steroids, broad-spectrum immunosuppressive drugs and anti-TNFa are effective in some patients for some time, but can have serious side-effects and the latter can be prohibitively expensive. Consequently, there is a pressing need for better treatments and novel research to uncover a cure(s) for IBD.
Many studies have demonstrated that epithelial permeability is increased in patients with IBD - that is, these individuals have reduced barrier function, at least temporarily. Maintaining an effective barrier requires energy and the mitochondrion is the body's and cells' power station generating the vast majority of its energy. Intuitively one might accept that a mitochondrial dysfunction would lead to loss of gut barrier function. Perturbation of cell function can lead to an endoplasmic reticulum (ER) response, and while ER-mitochondria communication is established the interaction of these two organelles in the control of gut permeability is unknown. Assessing this possibility, a series of experiments with cell lines, tissue samples from patients and commensal bacteria will be performed. A number of drugs that target mitochondrial and ER activity are available and their anti-inflammatory effect can be determined using promotion of a stable intestinal epithelial barrier as the primary experimental readout. By understanding factors that control gut epithelial barrier function and mechanisms to enhance this, new approaches to the treatment and a cure for IBD will emerge.
Department
Program
Fellowship - Priority Announcement: Gastroenterology
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
339957
Name
Lopes Fernando C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Allergen NCE; Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Mitochondria, endoplasmic reticulum (ER stress) and autophagy regulate gut permeability
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$30,740
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Gastroenterology
Keyworddelim
Atg16l1; Autophagy; Endoplasmic Reticulum; Inflammatory Bowel Diseases; Mitochondria; Unfolded Protein Response
Abstract
Canada has one of the highest global incidences and prevalence of inflammatory bowel diseases (IBD). The IBDs, Crohn's disease and ulcerative colitis, are chronic, painful and severely debilitating conditions characterized by relapsing bouts of disease with water/bloody diarrhea, which significantly reduce a patients' and their care-givers quality-of-life. IBD is idiopathic and cures await discovery. Current therapies, such as steroids, broad-spectrum immunosuppressive drugs and anti-TNFa are effective in some patients for some time, but can have serious side-effects and the latter can be prohibitively expensive. Consequently, there is a pressing need for better treatments and novel research to uncover a cure(s) for IBD.
Many studies have demonstrated that epithelial permeability is increased in patients with IBD - that is, these individuals have reduced barrier function, at least temporarily. Maintaining an effective barrier requires energy and the mitochondrion is the body's and cells' power station generating the vast majority of its energy. Intuitively one might accept that a mitochondrial dysfunction would lead to loss of gut barrier function. Perturbation of cell function can lead to an endoplasmic reticulum (ER) response, and while ER-mitochondria communication is established the interaction of these two organelles in the control of gut permeability is unknown. Assessing this possibility, a series of experiments with cell lines, tissue samples from patients and commensal bacteria will be performed. A number of drugs that target mitochondrial and ER activity are available and their anti-inflammatory effect can be determined using promotion of a stable intestinal epithelial barrier as the primary experimental readout. By understanding factors that control gut epithelial barrier function and mechanisms to enhance this, new approaches to the treatment and a cure for IBD will emerge.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lopes, Fernando C
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $30,740~ $0~